Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -345.15x is in line with its 5-year average of -316.53x, near the high end of its 5-year range (-6296.00x–-0.77x).
1459.31% below its 12-month average of -22.13x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2025 (2025-09-30): -64.29x.
INTEREST COVERAGE RATIO
-345.15x
INTEREST COVERAGE RATIO AVG TTM
-22.13x
INTEREST COVERAGE RATIO AVG 3Y
-195.89x
INTEREST COVERAGE RATIO AVG 5Y
-316.53x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1459.31%
CURRENT VS 3Y AVG
-76.20%
CURRENT VS 5Y AVG
-9.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.07x
median of 333 covered companies
CURRENT VS SECTOR MEDIAN
-8380.34%
vs the sector median at left
Ernexa Therapeutics Inc.
Market Cap
$4.49M
Interest Coverage Ratio
-345.15x
TTM Avg
-22.13x
3Y Avg
-195.89x
5Y Avg
-316.53x
Market Cap
$4.50M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.40M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$4.63M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$4.29M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$4.80M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.81M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.85M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | $4.49M | -345.15x | -22.13x | -195.89x | -316.53x |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | -765.53x | 1.76x | 1.76x | 1.76x |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.63M | N/A | 1.10x | 1.10x | 1.10x |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.29M | -21.32x | 128.62x | 128.62x | 128.62x |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | N/A | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.81M | -2.90x | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -16.26x | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | N/A | N/A | N/A | N/A |
Interest Coverage
-345.1x
Debt/Equity
0.11
Current Ratio
2.01
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -64.29x |
| 2024-12-31 | -0.77x |
| 2024-09-30 | -1.34x |
| 2024-06-30 | -6.19x |
| 2024-03-31 | -7.36x |
| 2023-12-31 | -14.86x |
| 2023-09-30 | -48.29x |
| 2022-12-31 | -789.50x |
| 2022-09-30 | -830.40x |
| 2022-06-30 | -1067.69x |
| 2022-03-31 | -6296.00x |
| 2021-12-31 | -473.48x |
| 2021-09-30 | -4313.80x |
| 2021-06-30 | -455.14x |
| 2021-03-31 | -637.21x |
| 2020-12-31 | -191.59x |
| 2020-09-30 | -159.85x |
